Meeting

Virtual Roundtable: What a World Without Chevron Means for U.S. Health

Tuesday, February 13, 2024
REUTERS/Jonathan Erns
Speaker
Nicholas Bagley

Thomas G. Long Professor of Law, University of Michigan Law School

Presider

Bloomberg Chair in Global Health; Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council on Foreign Relations

from Global Health, Economics, and Development Roundtable Series, Global Health Program, and Renewing America

In January, the U.S. Supreme Court debated whether to overturn Chevron v. Natural Resources Defense Council—one of the most cited U.S. cases of all time, which established the principle that the courts should defer to federal agencies when they interpret the law in the course of carrying out their duties. During the COVID-19 pandemic, the deference owed to federal agencies’ exercise of public health authorities was already heavily litigated. How much overruling Chevron would alter U.S. health policymaking is a matter of debate, with some claiming the change would be modest while others argue that FDA decision-making and Medicare administration would be rendered unworkable.

Mr. Nicholas Bagley, the Thomas G. Long Professor of Law at Michigan Law and an expert on administrative law and health law, and Thomas J. Bollyky discuss what replacing the Chevron doctrine might mean for U.S. health.

Top Stories on CFR

Climate Change

The legislation promoted by Trump and the White House will undo many of the climate and energy initiatives and tax credit programs passed during the Joe Biden administration.

Iran

Countries without nuclear weapons could decide nuclear nonproliferation and transparency efforts that the world has taken for granted now pose more risk than reward.

Ukraine

President Donald Trump is right to pursue diplomacy in Ukraine, but success requires a dual approach. To deliver on his promise to end the Russia-Ukraine war, Trump will need to offer Russia sticks as well as carrots.